Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New eye injection aims to save corneal cells after cataract surgery

NCT ID NCT05587205

First seen Jan 09, 2026 · Last updated May 24, 2026 · Updated 20 times

Summary

This early-stage study tests the safety of an experimental eye injection called EO2002 given right after cataract surgery. The goal is to see if it can help protect the thin layer of cells on the inside of the cornea, which often gets damaged during surgery. About 32 adults with cataracts and low corneal cell counts will take part, and half will receive the real injection while the other half gets a sham (fake) procedure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CATARACT are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Asociacion para Evitar la Ceguera en Mexico

    RECRUITING

    Mexico City, Mexico City, 04030, Mexico

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.